Skip to content
2000
Volume 26, Issue 41
  • ISSN: 0929-8673
  • E-ISSN: 1875-533X

Abstract

Heterocyclic compounds represent a significant target for anti-cancer research and drug discovery, due to their structural and chemical diversity. Oxazoles, with oxygen and nitrogen atoms present in the core structure, enable various types of interactions with different enzymes and receptors, favoring the discovery of new drugs. Aim of this review is to describe the most recent reports on the use of oxazole-based compounds in anticancer research, with reference to the newly discovered iso/oxazole-based drugs, to their synthesis and to the evaluation of the most biologically active derivatives. The corresponding dehydrogenated derivatives, i.e. iso/oxazolines and iso/oxazolidines, are also reported.

Loading

Article metrics loading...

/content/journals/cmc/10.2174/0929867326666181203130402
2019-12-01
2025-07-04
Loading full text...

Full text loading...

/content/journals/cmc/10.2174/0929867326666181203130402
Loading

  • Article Type:
    Review Article
Keyword(s): anticancer activity; isoxazole; Oxazole; oxazolidine; oxazoline; synthesis
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test